A Study on the Efficacy and Safety of Long-Term Treatment and Re-Treatment of Lower Extremity Diabetic Ulcers With REGRANEX

Clinical trial NCT00034788 · TERMINATED

Trial details

NCT number: NCT00034788
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Foot Ulcer Diabetic Foot Skin Ulcer Diabetic Neuropathies

Start date: 2000-12-01
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.